 Single-use Bioprocessing Market Insights, Competitive Landscape, and Market Forecast - 2033
The global single-use bioprocessing market is gaining strong momentum as biopharmaceutical manufacturers shift toward faster, cleaner, and more flexible production systems. The market is valued at ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global single-use bioprocessing market is gaining strong momentum as biopharmaceutical manufacturers shift toward faster, cleaner, and more flexible production systems. The market is valued at US$34.8 Bn in 2026 and is projected to reach US$75.5 Bn by 2033, expanding at a CAGR of 11.70% during the forecast period. Single-use technologies, including disposable bags, bioreactors, tubing assemblies, filters, mixers, and storage systems, are becoming central to modern biologics manufacturing because they reduce cleaning requirements, lower contamination risks, and support rapid facility changeovers. As demand for monoclonal antibodies, vaccines, therapeutic proteins, and cell and gene therapies continues to rise, companies are increasingly adopting single-use platforms to improve operational agility and accelerate time-to-market.Market Insights Single-use bioprocessing has moved from a supporting technology to a strategic manufacturing approach across upstream and downstream workflows. Biopharmaceutical companies are using disposable systems to reduce capital investment, minimize validation complexity, and support multiproduct manufacturing environments. The technology is especially valuable for small-batch, high-value biologics where flexibility and speed are critical. Consumables remain a major revenue contributor due to recurring demand for bags, tubing, connectors, filters, and assemblies, while equipment such as single-use bioreactors and mixing systems advances in scale, automation, and process control. The growing preference for modular manufacturing facilities is also strengthening market adoption, particularly among companies seeking faster capacity expansion without the burden of traditional stainless-steel infrastructure. Drivers The market is primarily driven by rising biologics production, expanding biosimilar pipelines, and increasing investment in advanced therapies. Single-use systems help manufacturers reduce downtime between production campaigns and improve facility utilization, which is essential as companies manage complex product portfolios. The need to limit cross-contamination is another major driver, especially in facilities handling multiple biologics or personalized therapies. In addition, the technology supports faster clinical and commercial manufacturing scale-up, making it attractive for emerging biotechnology firms and contract manufacturers. Growing vaccine development, pandemic preparedness programs, and demand for rapid-response manufacturing capacity are further increasing the use of disposable bioprocessing solutions across global production networks. Business Opportunity Significant opportunities exist for suppliers that can deliver integrated, scalable, and reliable single-use solutions. Manufacturers are looking for systems that combine bioreactors, sensors, connectors, filtration units, and data-enabled monitoring into seamless workflows. Demand is rising for high-performance films, leak-proof assemblies, sterile fluid transfer systems, and closed processing technologies that improve process security. Companies offering customized solutions for cell and gene therapy manufacturing are well positioned, as these therapies require flexible, small-volume, and contamination-controlled production environments. There is also growing opportunity in emerging markets where new biomanufacturing facilities are being built with single-use platforms from the beginning, allowing faster deployment and lower upfront investment. Region Analysis North America holds a leading position in the single-use bioprocessing market due to its strong biopharmaceutical manufacturing base, advanced research infrastructure, and high investment in biologics and cell therapy development. The United States remains a key contributor, supported by established biotechnology clusters, contract development and manufacturing organizations, and continuous innovation in disposable bioprocessing platforms. Europe is also a major market, with strong adoption across Germany, Switzerland, the United Kingdom, France, and other biomanufacturing hubs. Regulatory emphasis on quality, sterility, and process efficiency is supporting broader use of single-use systems across the region. Asia Pacific is expected to register rapid growth as countries such as China, India, South Korea, Japan, and Singapore expand biologics manufacturing capacity. Government support for domestic vaccine production, biosimilars, and biotechnology innovation is encouraging investment in flexible manufacturing infrastructure. Latin America and the Middle East & Africa are gradually adopting single-use technologies as local pharmaceutical production expands and regional healthcare systems focus on improving access to biologics. Key Players The competitive landscape includes global life science technology providers, filtration specialists, equipment manufacturers, and bioprocessing solution companies. Key players are focusing on product innovation, strategic partnerships, capacity expansion, and integrated workflow solutions to strengthen their market positions. Companies are also investing in supply chain resilience for single-use consumables, as reliable availability of sterile components has become a critical factor for biomanufacturers. Key players operating in the market include: • Thermo Fisher Scientific • Sartorius AG • Danaher Corporation • Eppendorf AG • Merck KGaA (MilliporeSigma) • Pall Corporation (part of Danaher) • Parker Hannifin Corporation • 3M Company • Corning Incorporated • Terumo Corporation • Avista Innovations, LLC • CellGenix GmbH • Sekisui XenoTech, LLC • Repligen Corporation • PBS Biotech Market Outlook The global outlook for the single-use bioprocessing market remains positive as manufacturers continue to prioritize flexibility, speed, and cost efficiency. As biologics pipelines expand and therapies become more targeted, production systems must support smaller batches, faster changeovers, and higher sterility assurance. Single-use platforms are expected to play a central role in next-generation manufacturing strategies, particularly as automation, process analytics, and closed-system designs become more advanced. Although concerns around extractables, leachables, waste management, and supply chain reliability remain important, continued material innovation and stronger supplier quality systems are expected to address these challenges. The market’s projected rise from US$34.8 Bn in 2026 to US$75.5 Bn by 2033 reflects the growing role of disposable technologies in shaping the future of biopharmaceutical production. Segmentation By Product: • Equipment • Consumables By Application: • Cell Culture • Filtration • Purification • Mixing • Storage & Transfer • Other By Workflow: • Upstream Bioprocessing • Downstream Bioprocessing By Molecule Type: • Monoclonal Antibodies (mAbs) • Vaccines • Therapeutic Proteins & Peptides • Cell & Gene Therapies By End User: • Pharmaceutical & Biotechnology Companies • CROs & CMOs • Other End Users By Geography: • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Single-use Bioprocessing Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global Single-use Bioprocessing Market Outlook, 2020 - 2033 3.1. Global Single-use Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033 3.1.1. Equipment 3.1.2. Consumables 3.2. Global Single-use Bioprocessing Market Outlook, by Application, Value (US$ Bn), 2020-2033 3.2.1. Cell Culture 3.2.2. Filtration 3.2.3. Purification 3.2.4. Mixing 3.2.5. Storage & Transfer 3.2.6. Other 3.3. Global Single-use Bioprocessing Market Outlook, by Workflow, Value (US$ Bn), 2020-2033 3.3.1. Upstream Bioprocessing 3.3.2. Downstream Bioprocessing 3.4. Global Single-use Bioprocessing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033 3.4.1. Monoclonal Antibodies (mAbs) 3.4.2. Vaccines 3.4.3. Therapeutic Proteins & Peptides 3.4.4. and Cell & Gene Therapies 3.5. Global Single-use Bioprocessing Market Outlook, by End User, Value (US$ Bn), 2020-2033 3.5.1. Pharmaceutical & Biotechnology Companies 3.5.2. CROs & CMOs 3.5.3. and Other End Users 3.6. Global Single-use Bioprocessing Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Latin America 3.6.5. Middle East & Africa 4. North America Single-use Bioprocessing Market Outlook, 2020 - 2033 4.1. North America Single-use Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033 4.1.1. Equipment 4.1.2. Consumables 4.2. North America Single-use Bioprocessing Market Outlook, by Application, Value (US$ Bn), 2020-2033 4.2.1. Cell Culture 4.2.2. Filtration 4.2.3. Purification 4.2.4. Mixing 4.2.5. Storage & Transfer 4.2.6. Other 4.3. North America Single-use Bioprocessing Market Outlook, by Workflow, Value (US$ Bn), 2020-2033 4.3.1. Upstream Bioprocessing 4.3.2. Downstream Bioprocessing 4.4. North America Single-use Bioprocessing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033 4.4.1. Monoclonal Antibodies (mAbs) 4.4.2. Vaccines 4.4.3. Therapeutic Proteins & Peptides 4.4.4. and Cell & Gene Therapies 4.5. North America Single-use Bioprocessing Market Outlook, by End User, Value (US$ Bn), 2020-2033 4.5.1. Pharmaceutical & Biotechnology Companies 4.5.2. CROs & CMOs 4.5.3. and Other End Users 4.6. North America Single-use Bioprocessing Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.6.1. U.S. Single-use Bioprocessing Market Outlook, by Product, 2020-2033 4.6.2. U.S. Single-use Bioprocessing Market Outlook, by Application, 2020-2033 4.6.3. U.S. Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 4.6.4. U.S. Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 4.6.5. U.S. Single-use Bioprocessing Market Outlook, by End User, 2020-2033 4.6.6. Canada Single-use Bioprocessing Market Outlook, by Product, 2020-2033 4.6.7. Canada Single-use Bioprocessing Market Outlook, by Application, 2020-2033 4.6.8. Canada Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 4.6.9. Canada Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 4.6.10. Canada Single-use Bioprocessing Market Outlook, by End User, 2020-2033 4.7. BPS Analysis/Market Attractiveness Analysis 5. Europe Single-use Bioprocessing Market Outlook, 2020 - 2033 5.1. Europe Single-use Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033 5.1.1. Equipment 5.1.2. Consumables 5.2. Europe Single-use Bioprocessing Market Outlook, by Application, Value (US$ Bn), 2020-2033 5.2.1. Cell Culture 5.2.2. Filtration 5.2.3. Purification 5.2.4. Mixing 5.2.5. Storage & Transfer 5.2.6. Other 5.3. Europe Single-use Bioprocessing Market Outlook, by Workflow, Value (US$ Bn), 2020-2033 5.3.1. Upstream Bioprocessing 5.3.2. Downstream Bioprocessing 5.4. Europe Single-use Bioprocessing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033 5.4.1. Monoclonal Antibodies (mAbs) 5.4.2. Vaccines 5.4.3. Therapeutic Proteins & Peptides 5.4.4. and Cell & Gene Therapies 5.5. Europe Single-use Bioprocessing Market Outlook, by End User, Value (US$ Bn), 2020-2033 5.5.1. Pharmaceutical & Biotechnology Companies 5.5.2. CROs & CMOs 5.5.3. and Other End Users 5.6. Europe Single-use Bioprocessing Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.6.1. Germany Single-use Bioprocessing Market Outlook, by Product, 2020-2033 5.6.2. Germany Single-use Bioprocessing Market Outlook, by Application, 2020-2033 5.6.3. Germany Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 5.6.4. Germany Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 5.6.5. Germany Single-use Bioprocessing Market Outlook, by End User, 2020-2033 5.6.6. Italy Single-use Bioprocessing Market Outlook, by Product, 2020-2033 5.6.7. Italy Single-use Bioprocessing Market Outlook, by Application, 2020-2033 5.6.8. Italy Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 5.6.9. Italy Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 5.6.10. Italy Single-use Bioprocessing Market Outlook, by End User, 2020-2033 5.6.11. France Single-use Bioprocessing Market Outlook, by Product, 2020-2033 5.6.12. France Single-use Bioprocessing Market Outlook, by Application, 2020-2033 5.6.13. France Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 5.6.14. France Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 5.6.15. France Single-use Bioprocessing Market Outlook, by End User, 2020-2033 5.6.16. U.K. Single-use Bioprocessing Market Outlook, by Product, 2020-2033 5.6.17. U.K. Single-use Bioprocessing Market Outlook, by Application, 2020-2033 5.6.18. U.K. Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 5.6.19. U.K. Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 5.6.20. U.K. Single-use Bioprocessing Market Outlook, by End User, 2020-2033 5.6.21. Spain Single-use Bioprocessing Market Outlook, by Product, 2020-2033 5.6.22. Spain Single-use Bioprocessing Market Outlook, by Application, 2020-2033 5.6.23. Spain Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 5.6.24. Spain Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 5.6.25. Spain Single-use Bioprocessing Market Outlook, by End User, 2020-2033 5.6.26. Russia Single-use Bioprocessing Market Outlook, by Product, 2020-2033 5.6.27. Russia Single-use Bioprocessing Market Outlook, by Application, 2020-2033 5.6.28. Russia Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 5.6.29. Russia Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 5.6.30. Russia Single-use Bioprocessing Market Outlook, by End User, 2020-2033 5.6.31. Rest of Europe Single-use Bioprocessing Market Outlook, by Product, 2020-2033 5.6.32. Rest of Europe Single-use Bioprocessing Market Outlook, by Application, 2020-2033 5.6.33. Rest of Europe Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 5.6.34. Rest of Europe Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 5.6.35. Rest of Europe Single-use Bioprocessing Market Outlook, by End User, 2020-2033 5.7. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Single-use Bioprocessing Market Outlook, 2020 - 2033 6.1. Asia Pacific Single-use Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033 6.1.1. Equipment 6.1.2. Consumables 6.2. Asia Pacific Single-use Bioprocessing Market Outlook, by Application, Value (US$ Bn), 2020-2033 6.2.1. Cell Culture 6.2.2. Filtration 6.2.3. Purification 6.2.4. Mixing 6.2.5. Storage & Transfer 6.2.6. Other 6.3. Asia Pacific Single-use Bioprocessing Market Outlook, by Workflow, Value (US$ Bn), 2020-2033 6.3.1. Upstream Bioprocessing 6.3.2. Downstream Bioprocessing 6.4. Asia Pacific Single-use Bioprocessing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033 6.4.1. Monoclonal Antibodies (mAbs) 6.4.2. Vaccines 6.4.3. Therapeutic Proteins & Peptides 6.4.4. and Cell & Gene Therapies 6.5. Asia Pacific Single-use Bioprocessing Market Outlook, by End User, Value (US$ Bn), 2020-2033 6.5.1. Pharmaceutical & Biotechnology Companies 6.5.2. CROs & CMOs 6.5.3. and Other End Users 6.6. Asia Pacific Single-use Bioprocessing Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.6.1. China Single-use Bioprocessing Market Outlook, by Product, 2020-2033 6.6.2. China Single-use Bioprocessing Market Outlook, by Application, 2020-2033 6.6.3. China Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 6.6.4. China Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 6.6.5. China Single-use Bioprocessing Market Outlook, by End User, 2020-2033 6.6.6. Japan Single-use Bioprocessing Market Outlook, by Product, 2020-2033 6.6.7. Japan Single-use Bioprocessing Market Outlook, by Application, 2020-2033 6.6.8. Japan Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 6.6.9. Japan Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 6.6.10. Japan Single-use Bioprocessing Market Outlook, by End User, 2020-2033 6.6.11. South Korea Single-use Bioprocessing Market Outlook, by Product, 2020-2033 6.6.12. South Korea Single-use Bioprocessing Market Outlook, by Application, 2020-2033 6.6.13. South Korea Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 6.6.14. South Korea Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 6.6.15. South Korea Single-use Bioprocessing Market Outlook, by End User, 2020-2033 6.6.16. India Single-use Bioprocessing Market Outlook, by Product, 2020-2033 6.6.17. India Single-use Bioprocessing Market Outlook, by Application, 2020-2033 6.6.18. India Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 6.6.19. India Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 6.6.20. India Single-use Bioprocessing Market Outlook, by End User, 2020-2033 6.6.21. Southeast Asia Single-use Bioprocessing Market Outlook, by Product, 2020-2033 6.6.22. Southeast Asia Single-use Bioprocessing Market Outlook, by Application, 2020-2033 6.6.23. Southeast Asia Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 6.6.24. Southeast Asia Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 6.6.25. Southeast Asia Single-use Bioprocessing Market Outlook, by End User, 2020-2033 6.6.26. Rest of SAO Single-use Bioprocessing Market Outlook, by Product, 2020-2033 6.6.27. Rest of SAO Single-use Bioprocessing Market Outlook, by Application, 2020-2033 6.6.28. Rest of SAO Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 6.6.29. Rest of SAO Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 6.6.30. Rest of SAO Single-use Bioprocessing Market Outlook, by End User, 2020-2033 6.7. BPS Analysis/Market Attractiveness Analysis 7. Latin America Single-use Bioprocessing Market Outlook, 2020 - 2033 7.1. Latin America Single-use Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033 7.1.1. Equipment 7.1.2. Consumables 7.2. Latin America Single-use Bioprocessing Market Outlook, by Application, Value (US$ Bn), 2020-2033 7.2.1. Cell Culture 7.2.2. Filtration 7.2.3. Purification 7.2.4. Mixing 7.2.5. Storage & Transfer 7.2.6. Other 7.3. Latin America Single-use Bioprocessing Market Outlook, by Workflow, Value (US$ Bn), 2020-2033 7.3.1. Upstream Bioprocessing 7.3.2. Downstream Bioprocessing 7.4. Latin America Single-use Bioprocessing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033 7.4.1. Monoclonal Antibodies (mAbs) 7.4.2. Vaccines 7.4.3. Therapeutic Proteins & Peptides 7.4.4. and Cell & Gene Therapies 7.5. Latin America Single-use Bioprocessing Market Outlook, by End User, Value (US$ Bn), 2020-2033 7.5.1. Pharmaceutical & Biotechnology Companies 7.5.2. CROs & CMOs 7.5.3. and Other End Users 7.6. Latin America Single-use Bioprocessing Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.6.1. Brazil Single-use Bioprocessing Market Outlook, by Product, 2020-2033 7.6.2. Brazil Single-use Bioprocessing Market Outlook, by Application, 2020-2033 7.6.3. Brazil Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 7.6.4. Brazil Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 7.6.5. Brazil Single-use Bioprocessing Market Outlook, by End User, 2020-2033 7.6.6. Mexico Single-use Bioprocessing Market Outlook, by Product, 2020-2033 7.6.7. Mexico Single-use Bioprocessing Market Outlook, by Application, 2020-2033 7.6.8. Mexico Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 7.6.9. Mexico Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 7.6.10. Mexico Single-use Bioprocessing Market Outlook, by End User, 2020-2033 7.6.11. Argentina Single-use Bioprocessing Market Outlook, by Product, 2020-2033 7.6.12. Argentina Single-use Bioprocessing Market Outlook, by Application, 2020-2033 7.6.13. Argentina Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 7.6.14. Argentina Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 7.6.15. Argentina Single-use Bioprocessing Market Outlook, by End User, 2020-2033 7.6.16. Rest of LATAM Single-use Bioprocessing Market Outlook, by Product, 2020-2033 7.6.17. Rest of LATAM Single-use Bioprocessing Market Outlook, by Application, 2020-2033 7.6.18. Rest of LATAM Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 7.6.19. Rest of LATAM Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 7.6.20. Rest of LATAM Single-use Bioprocessing Market Outlook, by End User, 2020-2033 7.7. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Single-use Bioprocessing Market Outlook, 2020 - 2033 8.1. Middle East & Africa Single-use Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033 8.1.1. Equipment 8.1.2. Consumables 8.2. Middle East & Africa Single-use Bioprocessing Market Outlook, by Application, Value (US$ Bn), 2020-2033 8.2.1. Cell Culture 8.2.2. Filtration 8.2.3. Purification 8.2.4. Mixing 8.2.5. Storage & Transfer 8.2.6. Other 8.3. Middle East & Africa Single-use Bioprocessing Market Outlook, by Workflow, Value (US$ Bn), 2020-2033 8.3.1. Upstream Bioprocessing 8.3.2. Downstream Bioprocessing 8.4. Middle East & Africa Single-use Bioprocessing Market Outlook, by Molecule Type, Value (US$ Bn), 2020-2033 8.4.1. Monoclonal Antibodies (mAbs) 8.4.2. Vaccines 8.4.3. Therapeutic Proteins & Peptides 8.4.4. and Cell & Gene Therapies 8.5. Middle East & Africa Single-use Bioprocessing Market Outlook, by End User, Value (US$ Bn), 2020-2033 8.5.1. Pharmaceutical & Biotechnology Companies 8.5.2. CROs & CMOs 8.5.3. and Other End Users 8.6. Middle East & Africa Single-use Bioprocessing Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.6.1. GCC Single-use Bioprocessing Market Outlook, by Product, 2020-2033 8.6.2. GCC Single-use Bioprocessing Market Outlook, by Application, 2020-2033 8.6.3. GCC Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 8.6.4. GCC Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 8.6.5. GCC Single-use Bioprocessing Market Outlook, by End User, 2020-2033 8.6.6. South Africa Single-use Bioprocessing Market Outlook, by Product, 2020-2033 8.6.7. South Africa Single-use Bioprocessing Market Outlook, by Application, 2020-2033 8.6.8. South Africa Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 8.6.9. South Africa Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 8.6.10. South Africa Single-use Bioprocessing Market Outlook, by End User, 2020-2033 8.6.11. Egypt Single-use Bioprocessing Market Outlook, by Product, 2020-2033 8.6.12. Egypt Single-use Bioprocessing Market Outlook, by Application, 2020-2033 8.6.13. Egypt Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 8.6.14. Egypt Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 8.6.15. Egypt Single-use Bioprocessing Market Outlook, by End User, 2020-2033 8.6.16. Nigeria Single-use Bioprocessing Market Outlook, by Product, 2020-2033 8.6.17. Nigeria Single-use Bioprocessing Market Outlook, by Application, 2020-2033 8.6.18. Nigeria Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 8.6.19. Nigeria Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 8.6.20. Nigeria Single-use Bioprocessing Market Outlook, by End User, 2020-2033 8.6.21. Rest of Middle East Single-use Bioprocessing Market Outlook, by Product, 2020-2033 8.6.22. Rest of Middle East Single-use Bioprocessing Market Outlook, by Application, 2020-2033 8.6.23. Rest of Middle East Single-use Bioprocessing Market Outlook, by Workflow, 2020-2033 8.6.24. Rest of Middle East Single-use Bioprocessing Market Outlook, by Molecule Type, 2020-2033 8.6.25. Rest of Middle East Single-use Bioprocessing Market Outlook, by End User, 2020-2033 8.7. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Thermo Fisher Scientific 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. Sartorius AG 9.4.3. Danaher Corporation 9.4.4. Eppendorf AG 9.4.5. Merck KGaA (MilliporeSigma) 9.4.6. Pall Corporation (part of Danaher) 9.4.7. Parker Hannifin Corporation 9.4.8. 3M Company 9.4.9. Corning Incorporated 9.4.10. Terumo Corporation 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Fairfield Market Research社の 医薬品・バイオテクノロジー分野 での最新刊レポート
本レポートと同じKEY WORD（landscape）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
